1. Immune Mechanism, Gene Module, and Molecular Subtype Identification of Astragalus Membranaceus in the Treatment of Dilated Cardiomyopathy: An Integrated Bioinformatics Study
   Xiao-yang Chen et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Traditional Chinese medicine on treating dilated cardiomyopathy
   Yuqing Tan et al, 2020, Medicine CrossRef
3. Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway
   Chunjun Li et al, 2023, Frontiers in Pharmacology CrossRef
4. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity
   Yanhe Lue et al, 2018, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
5. LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy
   Xue‐Feng Pang et al, 2020, Acta Physiologica CrossRef
6. Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis
   Chunzhen Ren et al, 2023, Journal of Ethnopharmacology CrossRef
7. Investigation of effects of traditional Chinese medicine astragalus heart-protecting decoction on rats with dilated cardiomyopathy
   Rongrong Sun et al, 2021, All Life CrossRef
8. Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
   Jianheng Pan et al, 2021, Frontiers in Pharmacology CrossRef
9. Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis
   Minghui Wang et al, 2024, Frontiers in Pharmacology CrossRef
10. Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines
    Rutao Bian et al, 2023, Frontiers in Molecular Biosciences CrossRef